215 related articles for article (PubMed ID: 16197721)
1. Pharmacogenetics and pediatric cancer.
Bomgaars L; McLeod HL
Cancer J; 2005; 11(4):314-23. PubMed ID: 16197721
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics in cancer treatment.
Nagasubramanian R; Innocenti F; Ratain MJ
Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681
[TBL] [Abstract][Full Text] [Related]
3. Drug methylation in cancer therapy: lessons from the TPMT polymorphism.
Krynetski E; Evans WE
Oncogene; 2003 Oct; 22(47):7403-13. PubMed ID: 14576848
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of folate-related drug targets in cancer treatment.
Robien K; Boynton A; Ulrich CM
Pharmacogenomics; 2005 Oct; 6(7):673-89. PubMed ID: 16207145
[TBL] [Abstract][Full Text] [Related]
5. Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions.
Wang L; Weinshilboum R
Oncogene; 2006 Mar; 25(11):1629-38. PubMed ID: 16550163
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacogenomic approaches for prevention of drug toxicity in cancer chemotherapy].
Hasegawa Y
Gan To Kagaku Ryoho; 2003 Mar; 30(3):325-33. PubMed ID: 12669388
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics and cancer chemotherapy.
Iyer L; Ratain MJ
Eur J Cancer; 1998 Sep; 34(10):1493-9. PubMed ID: 9893619
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
Bosch TM; Meijerman I; Beijnen JH; Schellens JH
Clin Pharmacokinet; 2006; 45(3):253-85. PubMed ID: 16509759
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetic determinants of anti-cancer drug activity and toxicity.
Danesi R; De Braud F; Fogli S; Di Paolo A; Del Tacca M
Trends Pharmacol Sci; 2001 Aug; 22(8):420-6. PubMed ID: 11479005
[TBL] [Abstract][Full Text] [Related]
10. Update on pharmacogenetics in cancer chemotherapy.
Innocenti F; Ratain MJ
Eur J Cancer; 2002 Mar; 38(5):639-44. PubMed ID: 11916544
[TBL] [Abstract][Full Text] [Related]
11. Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia.
Erčulj N; Kotnik BF; Debeljak M; Jazbec J; Dolžan V
Leuk Lymphoma; 2012 Jun; 53(6):1096-104. PubMed ID: 22074251
[TBL] [Abstract][Full Text] [Related]
12. Genetic determinants of cancer drug efficacy and toxicity: practical considerations and perspectives.
Candelaria M; Taja-Chayeb L; Arce-Salinas C; Vidal-Millan S; Serrano-Olvera A; Dueñas-Gonzalez A
Anticancer Drugs; 2005 Oct; 16(9):923-33. PubMed ID: 16162969
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of cytotoxic drugs.
Daly AK; Hall AG
Expert Rev Anticancer Ther; 2001 Aug; 1(2):301-8. PubMed ID: 12113035
[TBL] [Abstract][Full Text] [Related]
14. Cancer pharmacogenetics.
Marsh S; McLeod HL
Br J Cancer; 2004 Jan; 90(1):8-11. PubMed ID: 14710198
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
Bosch TM
Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics in chemotherapy of colorectal cancer.
Henriette Tanja L; Guchelaar HJ; Gelderblom H
Best Pract Res Clin Gastroenterol; 2009; 23(2):257-73. PubMed ID: 19414151
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacogenetics of anti-cancer drugs].
Gamelin E; Boisdron-Celle M; Morel A; Capitain O
Ann Pharm Fr; 2007 Nov; 65(6):390-401. PubMed ID: 18079671
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomics in drug-metabolizing enzymes catalyzing anticancer drugs for personalized cancer chemotherapy.
Fujita K; Sasaki Y
Curr Drug Metab; 2007 Aug; 8(6):554-62. PubMed ID: 17691917
[TBL] [Abstract][Full Text] [Related]
19. Fluoropyrimidine and platinum toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses.
Campbell JM; Bateman E; Peters MDj; Bowen JM; Keefe DM; Stephenson MD
Pharmacogenomics; 2016 Mar; 17(4):435-51. PubMed ID: 26894782
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of anti-cancer drugs: State of the art and implementation - recommendations of the French National Network of Pharmacogenetics.
Quaranta S; Thomas F
Therapie; 2017 Apr; 72(2):205-215. PubMed ID: 28262261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
